Aktieanalys

Respiratorius Q2 2022: On Track - Redeye

{newsItem.title}

Redeye Publicerad: 08 Nov 2022 11:41

Redeye comments on Respiratorius following the release of its shortened fiscal year 2022 Q2 report. The development of VAL001 seems to be progressing according to plan. We make some minor financial fine-tuning and adjust our fair value range.

Länk till analysen i sin helhet: https://www.redeye.se/research/861783/respiratorius-q2-2022-on-track?utm_source=finwire&utm_medium=RSS

Nyheter om Respiratorius

Läses av andra just nu

Om aktien Respiratorius

Senaste nytt